Treatments employing drug containing matrices for introduction into cellular lesion areas
USRE35748E · kind E · reissue
19Cited by
10References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 1995 |
| Grant date | Mar 17, 1998 |
| Priority date | — |
| Expiry date | Dec 19, 2015 |
Classification
- Technology area (CPC —)General
Abstract
Treatment of cellular disorders involving abnormal solid cellular growths involves introduction of cytotoxic reagents dispersed in a physiologically acceptable proteinaceous matrix into the solid cellular growth or area of an existing or removed solid cellular growth. Enhanced effectiveness of the drug is observed, with reduced cytotoxic effects on cells distant from the site of introduction. Other drugs may be included to enhance therapeutic gain and reduce adverse affects to normal tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.